|
End-of-day quote
Taiwan S.E.
2026-09-04
|
5-day change | 1st Jan Change | ||
| 48.05 TWD | +0.31% |
|
-4.28% | -22.12% |
| 08-14 | EirGenix Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 07-13 | EirGenix Partner Secures EMA Nod for Breast Cancer Biosimilar Vial | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 457M | - | - | - | - | - |
| 84.22B | |||||
| 60.48B | |||||
| 59.43B | - | ||||
| 50.31B | |||||
| 48.91B |
- Stock Market
- Stocks
- 6589 Stock
- Charts EirGenix Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
